BUSINESSBLOOMBERG
AstraZeneca Said to Have Explored Bristol Myers Merger
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers.
Related Signal
Adjacent reporting
- AstraZeneca said to have explored Bristol Myers merger
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
- AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
- STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs